Last reviewed · How we verify
NCT03175315: FLASH
Evaluation of a Treatment and Education Program for Diabetic Patients Who Use Flash Glucose Monitoring
NA trial testing Treatment and education program for patients with diabetes who use flash glucose monitoring (FLASH) in Diabetes Mellitus in 216 participants. Completed in 9 March 2018.
9 March 2018
Quick facts
| Lead sponsor | Norbert Hermanns |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 216 |
| Start date | 2 May 2017 |
| Primary completion | 9 March 2018 |
| Estimated completion | 9 March 2018 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Treatment and education program for patients with diabetes who use flash glucose monitoring (FLASH)
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Norbert Hermanns
Who can join
Adults 16 to 75, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a randomized, controlled, prospective trial with a 6-month follow- up. A newly developed psychoeducational treatment and education programme for diabetic patients on an insulin therapy who use flash glucose monitoring (FGM) will be tested compared to a waiting group. Primary outcome variable is the difference in glycemic control between baseline and the 6-month follow-up. Secondary outcome variables are: time-in-range, frequency and duration of hypo- and hyperglycemic episodes, diabetes-related distress, depressive symptoms, health-related quality of life, diabetes self-efficacy, self-care behavior, and hypoglycemia awareness.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The impact of a structured education and treatment programme (FLASH) for people with diabetes using a flash sensor-based glucose monitoring system: Results of a randomized controlled trial.
Hermanns N, Ehrmann D, Schipfer M, Kröger J, et al · · 2019 · cited 66× · PMID 30844467 · DOI 10.1016/j.diabres.2019.03.003 -
Makes FLASH the difference between the intervention group and the treatment-as-usual group in an evaluation study of a structured education and treatment programme for flash glucose monitoring devices in people with diabetes on intensive insulin therapy: study protocol for a rand
Schipfer M, Albrecht C, Ehrmann D, Haak T, et al · · 2018 · cited 1× · PMID 29402319 · DOI 10.1186/s13063-018-2479-9
Verify or expand the search:
- PubMed search for NCT03175315
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other Norbert Hermanns trials
Trials by the same sponsor.
- NCT04438018 — Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control in T2DM · completed
- NCT03811132 — Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control (DIA-LINK Study) · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03175315 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Norbert Hermanns
- Last refreshed: 3 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03175315.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing